Other substances

N-[3-[4-[4-(Hydroxymethyl)phenyl]-6-[[2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl]methyl]-1,3-dioxan-2-yl]phenyl]acetamide

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
1
 AI-suggested references
0
 Clinical trials

General information

N-[3-[4-[4-(Hydroxymethyl)phenyl]-6-[[2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl]methyl]-1,3-dioxan-2-yl]phenyl]acetamide on PubChem

Synonyms

PubChem3408741

 

Structure image - N-[3-[4-[4-(Hydroxymethyl)phenyl]-6-[[2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl]methyl]-1,3-dioxan-2-yl]phenyl]acetamide

CC(=O)NC1=CC=CC(=C1)C2OC(CC(O2)C3=CC=C(C=C3)CO)CN4CCCC4CN5CCCC5

Supporting references

Link Tested on Impact factor Notes Publication date
Using Chou’s 5-steps rule to study pharmacophore-based virtual screening of SARS-CoV-2 Mpro inhibitors
3CLpro Small molecule In silico 		in silico 2.03

Predicted to inhibit the SARS-CoV-2 3C-like protease.

 Oct/20/2020

AI-suggested references

Link Publication date
Using Chou's 5-steps rule to study pharmacophore-based virtual screening of SARS-CoV-2 Mpro inhibitors.
Oct/20/2020
Export (.csv)